Related Experiment Video

Updated: Sep 20, 2025

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.9K

Finding your niche: immune evasion in quiescent tumor reservoirs

Trever T Greene1, Katelynn R Kazane1, Elina I Zuniga1

  • 1Division of Biological Sciences, University of California, San Diego, CA 92093, USA.

Trends in Immunology
|June 7, 2022
PubMed

Insights

New research identifies unique, dormant cancer cells that evade immune attack, even when the immune system recognizes the tumor. Understanding these resilient quiescent cancer cells (QCCs) could improve immunotherapy effectiveness.

Area of Science:

  • Cancer Biology
  • Immunology
  • Metabolism

Background:

  • Emerging immunotherapies show promise for cancer treatment.
  • However, their effectiveness is limited, as tumors can evade immune surveillance.
  • A subpopulation of cancer cells may resist immune-mediated destruction.

Purpose of the Study:

  • To characterize a resilient cancer cell population.
  • To investigate the metabolic features of these cells.
  • To understand their resistance to T cell-mediated immunity.

Main Methods:

  • Analysis of cancer cell populations.
  • Metabolic profiling.
  • Assessment of T cell interactions with cancer cells.

Main Results:

  • Identification of a unique niche of quiescent cancer cells (QCCs).
  • These QCCs exhibit distinct metabolic characteristics.
  • QCCs demonstrated resistance to T cell-mediated control.

Conclusions:

  • Quiescent cancer cells represent a significant barrier to effective cancer immunotherapy.
  • Targeting the unique metabolism of QCCs may overcome treatment resistance.
  • Further research into QCCs is crucial for advancing cancer therapy.

More Related Videos

Author Spotlight: Identification and Isolation of Quiescent Leukemia Stem Cells from Zebrafish T-ALL06:41

Author Spotlight: Identification and Isolation of Quiescent Leukemia Stem Cells from Zebrafish T-ALL

Published on: July 19, 2024

975
An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth09:14

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth

Published on: August 11, 2011

16.0K

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.3K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
677